Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison R Greenplate

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Biorxiv : the Preprint Server for Biology|June 4, 2026
PD-1 blockade drug holiday improves exhausted progenitor CD8 T cell (Tpex) reinvigoration by avoiding Tpex adaptive resistanceShin Foong Ngiow, Ryan P O'Connell, Sasikanth Manne, et al.
Cytometry. Part B, Clinical Cytometry|July 19, 2017
Single Cell Analysis of Human Tissues and Solid Tumors with Mass CytometryNalin Leelatian, Deon B Doxie, Allison R Greenplate, et al.
Iscience|January 3, 2023
An extended SARS-CoV-2 mRNA vaccine prime-boost interval enhances B cell immunity with limited impact on T cellsAlexandre Nicolas, Gérémy Sannier, Mathieu Dubé, et al.
Cell|December 3, 2019
High-Throughput Mapping of B Cell Receptor Sequences to Antigen SpecificityIan Setliff, Andrea R Shiakolas, Kelsey A Pilewski, et al.
JCI Insight|June 15, 2017
Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinomaPeter J Siska, Kathryn E Beckermann, Frank M Mason, et al.
Nature Communications|January 30, 2016
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapyDouglas B Johnson, Monica V Estrada, Roberto Salgado, et al.
Cell Reports|October 19, 2022
SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinationsElizabeth M Anderson, Shuk Hang Li, Moses Awofolaju, et al.
Medrxiv : the Preprint Server for Health Sciences|September 28, 2021
Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individualsKatlyn Lederer, Kalpana Parvathaneni, Mark M Painter, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
Longitudinal Analysis Reveals Distinct Antibody and Memory B Cell Responses in SARS-CoV2 Naïve and Recovered Individuals Following mRNA VaccinationRishi R Goel, Sokratis A Apostolidis, Mark M Painter, et al.
Cell|February 26, 2021
In vivo CD8<sup>+</sup> T cell CRISPR screening reveals control by Fli1 in infection and cancerZeyu Chen, Eri Arai, Omar Khan, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Biorxiv : the Preprint Server for Biology|June 4, 2026
PD-1 blockade drug holiday improves exhausted progenitor CD8 T cell (Tpex) reinvigoration by avoiding Tpex adaptive resistanceShin Foong Ngiow, Ryan P O'Connell, Sasikanth Manne, et al.
Cytometry. Part B, Clinical Cytometry|July 19, 2017
Single Cell Analysis of Human Tissues and Solid Tumors with Mass CytometryNalin Leelatian, Deon B Doxie, Allison R Greenplate, et al.
Iscience|January 3, 2023
An extended SARS-CoV-2 mRNA vaccine prime-boost interval enhances B cell immunity with limited impact on T cellsAlexandre Nicolas, Gérémy Sannier, Mathieu Dubé, et al.
Cell|December 3, 2019
High-Throughput Mapping of B Cell Receptor Sequences to Antigen SpecificityIan Setliff, Andrea R Shiakolas, Kelsey A Pilewski, et al.
JCI Insight|June 15, 2017
Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinomaPeter J Siska, Kathryn E Beckermann, Frank M Mason, et al.
Nature Communications|January 30, 2016
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapyDouglas B Johnson, Monica V Estrada, Roberto Salgado, et al.
Cell Reports|October 19, 2022
SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinationsElizabeth M Anderson, Shuk Hang Li, Moses Awofolaju, et al.
Medrxiv : the Preprint Server for Health Sciences|September 28, 2021
Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individualsKatlyn Lederer, Kalpana Parvathaneni, Mark M Painter, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
Longitudinal Analysis Reveals Distinct Antibody and Memory B Cell Responses in SARS-CoV2 Naïve and Recovered Individuals Following mRNA VaccinationRishi R Goel, Sokratis A Apostolidis, Mark M Painter, et al.
Cell|February 26, 2021
In vivo CD8<sup>+</sup> T cell CRISPR screening reveals control by Fli1 in infection and cancerZeyu Chen, Eri Arai, Omar Khan, et al.
Pageof 8